EGFR and familial pancreatic carcinoma: The functional analysis showed that these PPPcs may facilitate anti- or pro-tumor effects of pancreatic cancer through the p53 signaling pathway, ErbB signaling pathway, VEGF signaling pathway, TGF-β signaling pathway, MAPK signaling pathway, and PI3K-Akt signaling pathway.